Avaliação das alterações do estado mental relacionadas ao vírus da imunodeficiência humana (HIV)

Última revisión: 19 Mar 2025
Última actualización: 31 Jul 2024

Resumen

Differentials

Common

  • Comprometimento neurocognitivo assintomático
  • Transtorno neurocognitivo leve (TNL)
  • Efeitos adversos de antirretrovirais
  • Encefalite/abscesso por toxoplasmose
  • Meningite/abscesso criptocócica
  • Meningite/abscesso por Mycobacterium tuberculosis
  • Depression
  • Uso de substâncias
  • Transtornos decorrentes do uso de bebidas alcoólicas
  • Coinfecção pelo vírus da hepatite C
  • Coinfecção pelo vírus da hepatite B
  • Hipogonadismo
Full details

Uncommon

  • Demência associada ao HIV (DAH)
  • Síndrome inflamatória da reconstituição imune
  • Neurossífilis
  • Encefalite por citomegalovírus (CMV)
  • Leucoencefalopatia multifocal progressiva
  • Encefalite por herpes-vírus
  • Encefalite por varicela-zóster
  • Linfoma primário do sistema nervoso central (SNC)
  • Deficiência de vitamina B12
  • Acidente vascular cerebral (AVC)
  • Hipotireoidismo
  • Insuficiência adrenal
Full details

Contributors

Authors

Marie-Josée Brouillette, MD, FRCPC

Associate Professor of Psychiatry/Consultant Psychiatrist

Chronic Viral Illness Service of the McGill University Health Centre

McGill University

Montreal

Canada

Disclosures

MJB declares that she has no competing interests.

Mark Hull, MD, MHSc, FRCPC

Clinical Assistant Professor

University of British Columbia

Division of AIDS

Faculty of Medicine

Vancouver

Canada

Disclosures

MH has received honoraria for speaking engagements and advisory boards from Gilead and Merck. These have been paid to his institution.

Marianne Harris, MD

Clinical Assistant Professor

University of British Columbia

Department of Family Practice

Faculty of Medicine

Vancouver

Canada

Disclosures

MH has served as a consultant and/or advisory board member for Gilead Sciences Canada Inc., Merck Canada Inc., and ViiV Healthcare. Honoraria are administered by the institution.

Acknowledgements

Dr Marie-Josée Brouillette, Dr Mark Hull, and Dr Marianne Harris would like to gratefully acknowledge Dr Martin Repetto, the previous contributor to this topic.

Disclosures

MR declares that he has no competing interests.

Peer reviewers

Joseph R. Zunt, MD, MPH

Associate Professor of Neurology

Harborview Medical Center

Seattle

WA

Disclosures

JRZ has received funding from NIH for research.

John Frater, MB BS, PhD

Consultant in Infectious Diseases

Nuffield Department of Experimental Medicine

University of Oxford

Oxford

UK

Disclosures

JF has received the MRC Clinician Scientist award.

  • Guidelines

    • Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV
    • EACS guidelines: version 11.1
    More Guidelines
  • Patient information

    Alzheimer's disease and other kinds of dementia

    Alzheimer's dementia: what are the treatment options?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer